Skip to main content
Explore URMC

menu

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients and Non-Cancer Control Participants With an Optional Sub-Study: Research Brain MRI

Research Question:
What are the effects of chemotherapy on cognitive function in breast cancer patients compared to the general population of age-matched, healthy control participants?

Basic Study Information

Purpose:
Study is enrolling newly diagnosed breast cancer patients about to start chemotherapy and age-matched control participants. The investigator is trying to better understand the prevalence of cognitive difficulties in cancer patients receiving chemotherapy compared to the general population as well as what biological mechanisms may play a role in the development of these difficulties. Patients will be asked to complete six assessments over the course of approximately 5 months. Assessments 1,3, 4.5 and 5 include computerized and paper and pencil cognitive testing as well as blood draws. Assessments 2 and 4 only involve the collection of a blood sample. An optional sub study is offered after Assessment 1. It involves a research brain MRI at Assessment 4.5 and cognitive testing and another research brain MRI at Assessment 6.

Location: University of Rochester
Study Reference #: RSRB 54027

Lead Researcher (Principal Investigator)

Lead Researcher: Michelle Janelsins-Benton

Study Contact Information

Study Coordinator: Sara Alberti
Phone: (585) 273-3998
Email: Sara_Alberti@urmc.rochester.edu

Additional Study Details

Study Details:
Parking voucher provided. Payment given upon completion of each assessment.

Number of Visits:  6 to 10
Parking:  Free
Transportation Coverage:  No
Reimbursement:  Yes

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search